TTY Biopharm Company Limited (TPEX:4105)
82.20
+0.90 (1.11%)
Nov 10, 2026, 1:30 PM CST
TTY Biopharm Company Market Cap
TTY Biopharm Company has a market cap or net worth of 20.44 billion as of November 9, 2026. It is the 12,923rd most valuable company in the world and the 400th biggest in Taiwan. Its market cap has increased by 3.66% in one year.
Market Cap
20.44B
Enterprise Value
20.38B
Revenue
6.81B
Global Rank
Country Rank
#400 Taiwan
PE Ratio
12.34
ChartMarket Cap Chart
Since July 3, 2003, TTY Biopharm Company's market cap has increased from 3.05B to 20.44B, an increase of 570.32%. That is a compound annual growth rate of 8.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 20.44B | 0.86% |
| Dec 31, 2025 | 20.26B | 11.95% |
| Dec 31, 2024 | 18.10B | -9.45% |
| Dec 29, 2023 | 19.99B | -3.60% |
| Dec 30, 2022 | 20.74B | 21.22% |
| Dec 30, 2021 | 17.11B | 0.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 50.85B |
| Lotus Pharmaceutical | 44.77B |
| Center Laboratories | 22.31B |
| Handa Pharmaceuticals | 16.98B |
| ScinoPharm Taiwan | 15.93B |
| YungShin Global Holding | 15.66B |
| Synmosa Biopharma | 14.72B |
| Grape King Bio | 11.93B |